RASSF1 and cancer: In addition, RASSF1C over-expression (but not RASSF1A over-expression) in human cancer cells enhances accumulation of the β-catenin oncogene, a key player in the Wnt signaling pathway, leading to increased transcriptional activation and cell proliferation [16].